Cingulate (CINGW) Current Assets (2021 - 2026)
Cingulate's (CINGW) quarterly Current Assets came in at $30.2 million in Q2 2026, up 151.56% quarter-over-quarter from $12.0 million in Q4 2025.
Analysis
Cingulate (CINGW) Current Assets (2021 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Current Assets for 6 consecutive years, with $30.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Assets changed N/A year-over-year to $30.2 million; the trailing twelve-month figure through Jun 2026 stood at $30.2 million (changed N/A YoY), and the FY2025 full-year result was $12.0 million, down 5.15% from the prior year.
- Current Assets rose to $30.2 million in Q2 2026 per CINGW's latest filing, from $12.0 million in the prior quarter.
- Across five years, Current Assets topped out at $30.2 million in Q2 2026 and bottomed at $578594.0 in Q4 2023.
- Historically, Current Assets has averaged $8.9 million across 5 years, with a median of $9.0 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Current Assets sank 92.65% in 2023, then soared 2088.2% in 2024.
- Over 5 years, Current Assets stood at $7.9 million in 2022, then tumbled by 92.65% to $578594.0 in 2023, then jumped by 2088.2% to $12.7 million in 2024, then decreased by 5.15% to $12.0 million in 2025, then soared by 151.56% to $30.2 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $30.2 million, $12.0 million, and $7.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 41.36 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | 36.64 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | 4.03 Bn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 6.03 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 3.48 Bn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 30.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.21 Mn |
| Dec 31, 2025 | 12.01 Mn |
| Sep 30, 2025 | 7.43 Mn |
| Mar 31, 2025 | 10.50 Mn |
| Dec 31, 2024 | 12.66 Mn |
| Sep 30, 2024 | 11.34 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 578,594.00 |
| Sep 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 2.04 Mn |
| Mar 31, 2023 | 3.75 Mn |
| Dec 31, 2022 | 7.87 Mn |
| Sep 30, 2022 | 11.83 Mn |
| Jun 30, 2022 | 10.10 Mn |
| Mar 31, 2022 | 14.57 Mn |
| Dec 31, 2021 | 18.88 Mn |